Effectiveness of ocrelizumab on clinical and MRI outcome measures in multiple sclerosis across black and white cohorts: A single-center retrospective study.

Amanda Frisosky Abuaf,Adil Javed,Samuel R Bunting,Timothy J Carroll,Anthony T Reder,Veronica P Cipriani

Multiple sclerosis and related disorders（2023）

引用 2|浏览7

暂无评分

摘要

In this real-world clinical and radiological study, ocrelizumab treatment was highly effective in stabilizing clinical and MRI measures of disease progression in Blacks and Whites, despite higher baseline disability in the Black cohort.

查看译文

关键词

Brain atrophy,Expanded disability status scale,Multiple sclerosis,Ocrelizumab,Racial differences,Therapeutic response

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要